The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of microRNA-21 with efficacy of cetuximab in RAS wild-type patients in the FIRE-3 study (AIO KRK-0306) and microRNA-21’s influence on gene expression in the EGFR signaling pathway.
 
Lisa Miller-Phillips
No Relationships to Disclose
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical
 
Arndt Stahler
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Florian Kaiser
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Leadership - IKF Klinische Krebsforschung
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience; Promedior; Roche
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma
 
Daniel Neureiter
No Relationships to Disclose
 
Christoph Kahl
No Relationships to Disclose
 
Frank Kullmann
No Relationships to Disclose
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; MSD; Nordic Group; Pfizer; Roche; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; German Cancer Society; Merck Serono; Nordic Bioscience; Roche
 
Werner Scheithauer
No Relationships to Disclose
 
Celine Vazart
Employment - IntegraGen
 
Karine Fontaine
Employment - Integragen
 
Swantje Held
No Relationships to Disclose
 
Dominik Paul Modest
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Pfizer; Roche; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Merck Serono
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Merck Serono; SERVIER
 
Jens Neumann
No Relationships to Disclose
 
Andreas Jung
No Relationships to Disclose
 
Thomas Kirchner
No Relationships to Disclose
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical; Takeda